News & Events
Phytolon Closes $23.6 Million Series B to Commercialize its Innovative Natural Food Colors
Earlier this year the FDA approved 'Beetroot Red', Phytolon's first product made by fermentation; the effective date is subject to FDA procedures
ElastiMed Announces Strategic Distribution Agreement with U.S. Medical Technology Company
This strategic distribution partnership enables access to ElastiMed’s compression device for the treatment of venous and lymphatic conditions.
Vensica Medical Advances Needle-Free Bladder Therapy to Phase 2
Vensica received FDA IND clearance to initiate Phase 2 study of ViXe, its needle-free Xeomin® delivery system for overactive bladder.
EcoPhage Submits EcoStraw® to EPA
Submission expands sustainable solutions for U.S. strawberry growers
Celleste Bio™ Unveils World’s First Milk Chocolate Bars Made with Cell Cultured Cocoa Butter
Milestone solidifies Celleste's capabilities to create scalable, commercial supply of real cocoa butter
Seger Surgical Solutions Achieves Milestone with Successful Human Trials of Laparoscopic Bowel Closure Device
Three Successful First-in-Human Cases Completed in El Salvador
IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides
POC included in vivo insect validation of de novo designed proteins
Arcuro Medical Significantly Expands SuperBall® Market Opportunity with New Rotator Cuff Repair System; Launches Newly-Enhanced Meniscus Repair System
New indications and enhancements target a potential $1.1 billion addressable market by 2028
Phytolon Achieves Major FDA Regulatory Milestone Paving the Way for Commercialization
The FDA approval paves the way for U.S. commercialization and uses across a wide range of food categories